October 2003
From American Chemical Society
Initial conference topics announced for 2004 ACS ProSpectives schedule The American Chemical Society, the world's largest scientific society, will hold eight ACS ProSpectives conferences in 2004, beginning in January, including one in April dealing with counterfeiting, tampering, diversion and theft of pharmaceutical products. Five conferences have been scheduled to date.ACS ProSpectives is a series of small conferences targeting industry scientists who work along the interface of chemistry and at least one other scientific discipline such as biology, physics and engineering. Each conference examines a field's most consequential topics through presentations by its foremost researchers. Attendance at the conferences is limited to 200 or fewer to optimize interaction among the participants. Conferences typically feature extended presentations from 15-25 of a field's leading researchers. The conferences are in addition to the Society's two national meetings and its eight to 10 regional meetings held every year. Following is the 2004 schedule announced to date: Organic Thin Film Electronics: Materials, Devices and Applications Chairs: C. Daniel Frisbie, University of Minnesota; Zhenan Bao, Lucent Technologies;
Christos Dimitrakopoulos, IBM Location: J.W. Marriott, Miami, Fla., Jan. 25-28, 2004 The recent commercialization of organic light-emitting display technology opens the question of how pervasive organic thin film electronics will become. Leading experts will discuss this question and state-of-the-art technical developments. Technical topics include organic light emitting diodes, organic photovoltaics, organic thin-film transistors, synthesis of new organic semiconductor materials, and the electronic properties of organic-metal contacts and organic-organic interfaces. Polymorphism in Crystals Chairs: Robin Rogers, The University of Alabama; Allan Myerson, Illinois Institute of Technology; Susan Reutzel-Edens, Eli Lilly & Company Location: Saddlebrook Resort, Tampa, Fla., Feb. 8-11, 2004 Polymorphism can often mean the difference between success and failure in several industries, notably pharmaceuticals. The scientific implications of polymorphism are often misunderstood, while the business aspects of polymorphism can lead to multimillion-dollar court cases. The state-of-the-art in this often-misunderstood field of crystalline polymorphism will be presented by leading experts in polymorph crystallization, characterization and prediction, with an emphasis on industrial implications and practice. Process Chemistry in the Pharmaceutical Industry Chairs: Kumar Gadamasetti, Delphian Pharmaceuticals; Margaret Faul, Eli Lilly & Company Location: Saddlebrook Resort, Tampa, Fla., Feb. 29 - March 3, 2004 The development of practical, cost-effective processes for the synthesis of new therapeutics has critical implications for subsequent manufacturing and commercialization. During this conference, leading experts will update the state-of-the-art in this area and outline the key techniques required for world-class process chemistry. Topics include heterocyclic chemistry, organometallic chemistry, asymmetric synthesis, technology and automation, biocatalysis and crystallization. There also will be a roundtable discussion on the regulatory aspects of this area of research. An investigative approach to all aspects of development and scale-up will be presented through a variety of industry case studies selected to illustrate key concepts. Pharmaceutical Authentication and Forensic Analysis Chairs: Frederick L. Fricke, Jr., FDA; Rafik H. Bishara, Eli Lilly & Company; Moheb M. Nasr, FDA; John P. Jasper, Molecular Isotope Technologies, LLC; Thomas Zimmer, Pharma USA, Mexico & Spain, Boehringer Ingelheim GmbH Location: Grand Hyatt Tampa Bay, Fla., April 25-27, 2004 The world's top experts from the pharmaceutical industry, government regulatory agencies, and academia will discuss applications of new and existing technologies in the larger context of creating strategies to prevent and detect counterfeit pharmaceutical products. Counterfeiting, tampering, diversion, theft and patent infringement compromise the integrity of pharmaceutical products and threaten the safety and well being of patients. Authenticating pharmaceuticals - raw materials, active pharmaceutical ingredients, inert substances and finished dosage forms - throughout the entire supply chain is essential for maintaining product integrity. This conference will provide the latest thinking on a wide spectrum of techniques designed to enhance the understanding of pharmaceutical authentication and forensic analysis. Emerging Opportunities in Chemical Sensing and Biosensing Chairs: Art Janata, Georgia Institute of Technology; Antonio J. Ricco, Microtechnologies & Biosystems, NASA Ames Research Center;
Boris Mizaikoff, Georgia Institute of Technology Location: Inn at Loretto, Santa Fe, N.M., May 16-19, 2004 Ever increasing demand for new data inputs, miniaturization and ample data-processing capacity help drive the development of new chemical sensors and biosensors. Selected invited international experts in the sensor field will present a broad spectrum of new developments in optical, electrochemical, mass and higher order chemical sensors, sensing systems and modern data reduction techniques. The emphasis will be on technologies that have reached maturity and are on the verge of transition from research laboratories to further industrial development. # # # Further details about the conferences, including instructions on how to register and arrange lodging, are available at www.acsprospectives.org. This site will be updated regularly with the latest information about upcoming ACS ProSpectives conferences.(EDITOR's NOTE - News media wishing to attend the conferences should contact Michael Bernstein at 202-872-6042 or at [email protected].) | |